{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Level+A&page=37", "query": { "intervention": "Level A", "page": 37 }, "page_size": 10 }, "pagination": { "page": 37, "page_size": 10, "total_count": 11742, "total_pages": 1175, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Level+A&page=38&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Level+A&page=36&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T08:33:02.708Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01158079", "title": "Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors" ], "interventions": [ { "name": "ALN-VSP02", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alnylam Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2010-07", "completion_date": "2012-09", "has_results": false, "last_update_posted_date": "2012-10-12", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 7, "location_summary": "Scottsdale, Arizona • Boston, Massachusetts • Detroit, Michigan + 2 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01158079" }, { "nct_id": "NCT05409079", "title": "Schulze Muscular Dystrophy Ability Clinical Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Muscular Dystrophies", "Spinal Muscular Atrophy", "Duchenne Muscular Dystrophy", "Limb Girdle Muscular Dystrophy", "FSHD", "Cerebral Palsy", "Becker Muscular Dystrophy" ], "interventions": [ { "name": "Abilitech Assist", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "AbiliTech Medical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 35, "start_date": "2022-05-26", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2022-12-05", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 1, "location_summary": "Saint Paul, Minnesota", "locations": [ { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05409079" }, { "nct_id": "NCT00218062", "title": "Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cocaine-Related Disorders" ], "interventions": [ { "name": "D-Amphetamine 30mg", "type": "DRUG" }, { "name": "D-Amphetamine 60mg", "type": "DRUG" }, { "name": "Modafinil 200mg", "type": "DRUG" }, { "name": "Modafinil 400mg", "type": "DRUG" }, { "name": "Therapy", "type": "BEHAVIORAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 73, "start_date": "2006-03", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2017-06-21", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00218062" }, { "nct_id": "NCT05560646", "title": "A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Endometriosis" ], "interventions": [ { "name": "OG-6219", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Organon and Co", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "18 Years to 49 Years · Female only" }, "enrollment_count": 354, "start_date": "2022-10-25", "completion_date": "2025-05-28", "has_results": true, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Los Angeles, California • Orange, Connecticut + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "Connecticut" }, { "city": "Sarasota", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05560646" }, { "nct_id": "NCT06104488", "title": "A Study of Avutometinib for People With Solid Tumor Cancers", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Refractory Cancer", "CNS Tumors", "CNS Tumor, Adult", "CNS Tumor, Childhood", "MAP Kinase Family Gene Mutation", "NF1", "Plexiform Neurofibroma", "Low-grade Glioma", "Optic Pathway Gliomas", "Neuroblastoma", "Primary Brain Tumor", "Solid Tumor", "Solid Tumor, Adult", "Solid Carcinoma", "Central Nervous System Tumor" ], "interventions": [ { "name": "Avutometinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "3 Years to 30 Years" }, "enrollment_count": 3, "start_date": "2023-10-20", "completion_date": "2029-10-20", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 2, "location_summary": "Atlanta, Georgia • New York, New York", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06104488" }, { "nct_id": "NCT06416670", "title": "Skilled Nursing Facility Care at Home", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Skilled Nursing Facility", "Rehabilitation" ], "interventions": [ { "name": "Skilled nursing facility care at home", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2024-06-03", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 5, "location_summary": "Boston, Massachusetts • Cambridge, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cambridge", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06416670" }, { "nct_id": "NCT06409169", "title": "DBS TaT in Peer-assisted Telemedicine for Hepatitis C", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "DBS TaT", "type": "OTHER" }, { "name": "Usual Care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 141, "start_date": "2025-01-22", "completion_date": "2026-11-08", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT06409169" }, { "nct_id": "NCT03118583", "title": "Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "300 mg/day of dietary supplement containing carrageenan", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Midwest Center for Metabolic and Cardiovascular Research", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "25 Years to 69 Years" }, "enrollment_count": 12, "start_date": "2017-03-15", "completion_date": "2018-01-31", "has_results": false, "last_update_posted_date": "2018-05-15", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 1, "location_summary": "Boca Raton, Florida", "locations": [ { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03118583" }, { "nct_id": "NCT04337970", "title": "Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Kidney Cancer", "Renal Cell Carcinoma", "Unresectable Renal Cell Carcinoma", "Metastatic Renal Cell Carcinoma" ], "interventions": [ { "name": "Talazoparib", "type": "DRUG" }, { "name": "Axitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2020-04-06", "completion_date": "2025-05-23", "has_results": true, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04337970" }, { "nct_id": "NCT05067556", "title": "Decreasing Long-term Opioid Use in Cancer Survivors", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Chronic Pain", "Cancer Pain", "Survivorship" ], "interventions": [ { "name": "Acceptance and Commitment Therapy for chronic pain (ACT-CP)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2021-12-20", "completion_date": "2028-03-30", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-27T08:33:02.708Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05067556" } ] }